In gynecology, zoledronic acid is most often associated with the treatment of postmenopausal osteoporosis. Women undergoing menopause experience a rapid decline in estrogen levels, which can lead to decreased bone density and increased risk of fractures. Zoledronic acid helps mitigate these risks by strengthening the bones. It is also used in patients with breast cancer to prevent bone complications that can arise from metastasis.
